Abstract:Objective To explore the expression of secreted phosphoprotein 1 (SPP1) in lung adenocarcinoma (LUAD), and evaluate its relationship with clinicopathological characteristics and prognosis of LUAD, and analyze the advantages of SPP1 as a potential prognostic marker in LUAD. Methods The expression of SPP1 in normal lung tissue and LUAD was analyzed from the Cancer Cell Line Encyclopedia (CCLE), Gene Expression Omnibus (GEO), and Human Protein Atlas (HPA) databases. GSE68465 was used to explore the relationship between the SPP1 expression and clinicopathological characteristics and the prognosis of LUAD patients. The relationship between SPP1 and immune infiltration in LUAD was analyzed by the Tumor Immune Estimation Resource (TIMER) database. Gene enrichment analysis was performed in GSEA. The Cancer Genome Atlas (TCGA)-LUAD data was used to verify the results. Results In the cell line level, non-small cell lung cancer ranked ninth among cancer cell lines based on SPP1 expression. In the messenger RNA (mRNA) and protein levels, SPP1 expression was higher in LUAD tissues than that in normal control. SPP1 expression was related to gender, N stage, histological grade, and progression or relapse. In men, SPP1 expression were higher compared to that in women. The higher the N stage, the higher the SPP1 expression level. As LUAD progresses or relapses, SPP1 expression could increase. In the pathological grade, the SPP1 expression was higher in LUAD samples with moderate differentiation. In addition, the overall 5-year survival rates of the SPP1 high and low expression groups were 50.574 and 59.181% [P= 0.008; hazard ratio (HR) = 0.7057; 95% CI, 0.5467-0.9109], indicating that SPP1 had an impact on overall survival for LUAD patients. The relationship between SPP1 expression and CD4(+)T cell, macrophage, neutrophil, and dendritic cell infiltration was weak in LUAD. SPP1 could be considered as an independent prognostic marker in LUAD (P= 0.003; HR = 1.150; 95% CI, 1.048-1.261) by multivariate Cox regression analysis. The results of GSEA indicated that samples with high SPP1 expression were enriched in protein secretion, mTORC1 signaling, angiogenesis, and glycolysis pathway. The analysis results obtained by TCGA-LUAD data were basically consistent with the results obtained by GSE68465. Conclusions SPP1 can not only affect the occurrence and development of LUAD but also may be an independent prognostic marker of LUAD. SPP1 is expected to be a new target for molecular targeted therapy.

Testes-specific Protease 50 As an Independent Risk Factor for Poor Prognosis in Patients with Non-Small Cell Lung Cancer

Lentivirus-Mediated Knockdown of Tsp50 Suppresses the Growth of Non-Small Cell Lung Cancer Cells Via G0/G1 Phase Arrest

Serum Levels of the Cancer-Testis Antigen POTEE and Its Clinical Significance in Non-Small Cell Lung Cancer.

[Expression of Protein-Tyrosine-phosphatase 1B in Non-Small-cell Lung Cancer and Its Prognostic Significance].

Clinicopathological and prognostic significance of heat shock protein 27 (HSP27) expression in non-small cell lung cancer: a systematic review and meta-analysis.

Role of TSP-1 As Prognostic Marker in Various Cancers: a Systematic Review and Meta-Analysis

Elevated of HSP90 associates with expression of EGFR levels and predicts poor prognosis in non-small cell lung cancer patients

High TMPRSS11D protein expression predicts poor overall survival in non-small cell lung cancer.

Prognostic Value of the Mrna Expression of Members of the HSP90 Family in Non-Small Cell Lung Cancer

Testes-specific Protease 50 (TSP50) Promotes Invasion and Metastasis by Inducing EMT in Gastric Cancer

The value of lung function assessment and Testin expression detection in clinicopathological features and prognosis of NSCLC patients

TSP50 facilitates breast cancer stem cell-like properties maintenance and epithelial-mesenchymal transition via PI3K p110α mediated activation of AKT signaling pathway

Expression of Thop1 and Its Relationship to Prognosis in Non-Small Cell Lung Cancer

Study of prognostic predictors for non-small cell lung cancer

Proteomic analysis of non-small cell lung cancer tissue interstitial fluids

Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer

Analysis of Expression and Its Clinical Significance of the Secreted Phosphoprotein 1 in Lung Adenocarcinoma.

SP1 Expression and the Clinicopathological Features of Tumors: A Meta-Analysis and Bioinformatics Analysis.

Testes-specific Protease 50 (TSP50) Promotes Cell Proliferation Through the Activation of the Nuclear Factor Κb (Nf-Κb) Signalling Pathway.

Increased Expression of TAP is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer

Prognostic Significance of Thymidylate Synthase in Postoperative Non-Small Cell Lung Cancer Patients